Wang, M. S.;# Xu, H. C.;# Gong, Y.;# Qu, R. Y.; Zhuo, L. S.;* Huang, W.* Efficient Arylation of 2,7-Naphthyridin-1(2H)‑one with Diaryliodonium Salts and Discovery of a New Selective MET/AXL Kinase Inhibitor. ACS. Comb. Sci. 2020, 22, 457-467. (IF2020 = 3.784，二区)
发布时间：2026-06-15
点击次数：
- 发布时间：
- 2026-06-15
- 论文名称：
- Wang, M. S.;# Xu, H. C.;# Gong, Y.;# Qu, R. Y.; Zhuo, L. S.;* Huang, W.* Efficient Arylation of 2,7-Naphthyridin-1(2H)‑one with Diaryliodonium Salts and Discovery of a New Selective MET/AXL Kinase Inhibitor. ACS. Comb. Sci. 2020, 22, 457-467. (IF2020 = 3.784，二区)
- 是否译文：
- 否
- 上一条：Zhuo, L. S.;# Wu, X. F.;# Wang, M. S.; # Xu, H. C.; Yang, F. P.; Tian, Y. G.; Zhao, X. E.; Ming, Z. H.; Zhu, X. L.; Hao, G. F.;* Huang, W.* Structure–activity relationship study of novel quinazoline-based 1,6-naphthyridinones as MET inhibitors with potent antitumor efficacy. Eur. J. Med. Chem. 2020, 208, 112785. (IF2020 = 6.514，一区)
- 下一条：Xu, H. C.;# Wang, M. S.;# Wu, X. F.;# Zhuo, L. S.*; Huang, W.*; She, N. F.* Discovery of N-substituted-3-phenyl-1,6-naphthyridinone Derivatives Bearing Quinoline Moiety as VEGFR-2 Selective Type II c-Met Kinase Inhibitors against VEGFR-2. Bioorg. Med. Chem. 2020, 28, 115555. (IF2020 = 3.641，二区)